Immediate Impact
2 from Science/Nature 70 standout
Citing Papers
Artificial intelligence in drug development
2025 Standout
Atopic dermatitis
2025 Standout
Works of Sarah Pearson being referenced
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
2016
Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sarah Pearson | 155 | 91 | 71 | 79 | 15 | 462 | |
| Ronald Westlund | 114 | 89 | 129 | 158 | 21 | 545 | |
| Jennifer Devlen | 161 | 62 | 47 | 35 | 19 | 518 | |
| Marci Clark | 68 | 52 | 51 | 53 | 21 | 479 | |
| Mark Toynbee | 116 | 64 | 18 | 20 | 17 | 455 | |
| Conan Donnelly | 229 | 103 | 60 | 15 | 23 | 464 | |
| Hao Tian | 48 | 49 | 93 | 60 | 34 | 491 | |
| R. Snyder | 108 | 46 | 154 | 84 | 20 | 555 | |
| Salïh Emri | 137 | 80 | 151 | 102 | 25 | 472 | |
| Giuseppina Gallucci | 112 | 14 | 77 | 72 | 31 | 487 | |
| Lampros Fotis | 51 | 63 | 49 | 28 | 21 | 454 |
All Works
Login with ORCID to disown or claim papers
Loading papers...